Company
Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF)
Standardized SEC financial data for Cordyceps Sunshine Biotech Holdings Co., Ltd. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001885680 · OTC · Medicinal Chemicals & Botanical Products.
Gross margin
61.1%
Operating margin
-11.3%
Net margin
-12.4%
Revenue growth (YoY)
-0.7%
Return on equity
29.0%
Free cash flow
-$385K
Debt / equity
-0.81×
Current ratio
0.19×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $879K | $53K | $883K | $1.3M | $1.2M |
| Cost of revenue | $1.1M | $14K |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $294 | $100K | $7K | $23K | $37K | $3K |
| Accounts receivable |
Cash flow
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | -$365K | -$395K | $360K | $312K | -$36K |
| Capital expenditures | $100K | $475 |
Get RAJAF data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/RAJAF/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/RAJAF/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"